http://panel.opinionhealth.com/ Fri, 23 Dec 2011 08:18:27 GMT A summary of the latest news on healthcare, as reported by the UK and International media http://panel.opinionhealth.com/r/9870 Merck and Co has terminated an agreement with Acumen to develop treatments for Alzheimer’s disease the same day it announced it has bought the licence to an R&D programme from Exelixis. Fri, 23 Dec 2011 08:18:27 GMT http://panel.opinionhealth.com/r/8900 PMLive http://panel.opinionhealth.com/r/9869 Bayer has delivered an optimistic appraisal of its pipeline prospects, highlighting four products which it believes will cross the €1bn sales barrier and become blockbusters. Fri, 23 Dec 2011 08:18:12 GMT http://panel.opinionhealth.com/r/8899 PMLive http://panel.opinionhealth.com/r/9867 AstraZeneca has signed two licensing deals with Asian drug developers to add new medicines for diabetes and cancer into its development pipeline. Fri, 23 Dec 2011 08:17:35 GMT http://panel.opinionhealth.com/r/8898 PMLive http://panel.opinionhealth.com/r/9866 Daiichi-Sankyo has halved its net income forecast after agreeing a $500m legal settlement for manufacturing violations by its Ranbaxy Laboratories unit. Fri, 23 Dec 2011 08:17:11 GMT http://panel.opinionhealth.com/r/8897 PMLive http://panel.opinionhealth.com/r/9865 Novocure has added three senior oncology executives to its global management team to support its new tumour treating fields (TTF) cancer therapy. Fri, 23 Dec 2011 08:16:53 GMT http://panel.opinionhealth.com/r/8896 PMLive http://panel.opinionhealth.com/r/9864 On April 1, the prices of 75 medicines supplied through Australia's Pharmaceutical Benefits Scheme (PBS) will be reduced by an average of 28.7%, saving the government an estimated A$1.9 billion over four years. Fri, 23 Dec 2011 08:16:36 GMT http://panel.opinionhealth.com/r/8895 http://panel.opinionhealth.com/r/9863 The European Union (EU)'s proposed new directive on public procurement will allow "more scope for negotiating with suppliers," according to the NHS Confederation. Fri, 23 Dec 2011 08:16:20 GMT http://panel.opinionhealth.com/r/8894 http://panel.opinionhealth.com/r/9862 More than one third of clinical trials conducted by pharmaceutical companies are now being outsourced, a new report has found. Fri, 23 Dec 2011 08:16:03 GMT http://panel.opinionhealth.com/r/8893 http://panel.opinionhealth.com/r/9861 The US Food and Drug Administration has now joined a probe to investigate the safety of Novartis’ oral multiple sclerosis drug Gilenya (fingolimod) after a patient died within 24 hours of taking the first dose. Fri, 23 Dec 2011 08:15:50 GMT http://panel.opinionhealth.com/r/8892 http://panel.opinionhealth.com/r/9860 Ranbaxy's stock slipped this week after the firm revealed it would be putting $500 million aside to cover any criminal and civil liabilities arising from an investigation by the US Department of Justice into manufacturing violations at a plant in Northern India. Fri, 23 Dec 2011 08:15:34 GMT http://panel.opinionhealth.com/r/8891 http://panel.opinionhealth.com/r/9859 The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a 12-week consultation on proposals to change some of the fees it charges for the regulation of medicines. Fri, 23 Dec 2011 08:15:18 GMT http://panel.opinionhealth.com/r/8890 http://panel.opinionhealth.com/r/9858 Australians born with birth defects after their mothers took thalidomide win right to have case heard in their own country Tue, 20 Dec 2011 08:35:05 GMT http://panel.opinionhealth.com/r/8889 The Guardian http://panel.opinionhealth.com/r/9857 New evidence shows that Thomas Lonngren, former head of the European Medicines Agency (EMA), set up his own consultancy business to advise pharmaceutical industry clients while he was still employed as the EMA's head, according to pressure groups. Tue, 20 Dec 2011 08:34:47 GMT http://panel.opinionhealth.com/r/8888 http://panel.opinionhealth.com/r/9855 The latest set of opinions from the European Medicines Agency has brought good news for Roche and Daiichi Sankyo's personalised cancer drug Zelboraf. Tue, 20 Dec 2011 08:34:33 GMT http://panel.opinionhealth.com/r/8887 http://panel.opinionhealth.com/r/9854 ISTA Pharmaceuticals has rejected a hostile takeover bid from Valeant Pharmaceuticals International worth around $327 million, describing the proposal as "grossly inadequate". Tue, 20 Dec 2011 08:34:16 GMT http://panel.opinionhealth.com/r/8886